DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sai Parenterals Limited — Monitoring Agency Report

NSE 1 hr ago·3 Oct 2026, 6:39 am

SAI Parenterals

Sai Parenterals Limited has disclosed a monitoring agency report for the quarter ended June 30, 2026. This document provides an independent assessment of the company's financial health and operational performance during the specified period.

For investors, this report is a key tool for validating the company's reported figures. It offers an external perspective on the firm's stability and can help in assessing the accuracy of its disclosures before the official financial results are released.

Investors should pay close attention to any discrepancies between the monitoring agency's findings and the company's own statements. This information is crucial for making informed decisions as the stock approaches its earnings announcement.